The role of iron overload on oxidative stress in sickle cell anemia

Biomarkers in Medicine

Volumn 6, Issue 6, 2012, Pages 813-819

  Dos Santos, Talyta Ellen De Jesus ^a   De Sousa, Geane Félix ^a   Barbosa, Maritza Cavalcante ^a   Gonçalves, Romélia Pinheiro ^a  

^a FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

Author keywords

iron overload; oxidative stress; sickle cell anemia

Indexed keywords

CATALASE; DEFERASIROX; FERRITIN; HYDROXYUREA; MALONALDEHYDE; NITRITE; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; TRANSFERRIN;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EFFICACY; DRUG SAFETY; ENZYME ACTIVITY; ERYTHROCYTE; ERYTHROCYTE COUNT; FEMALE; FERRITIN BLOOD LEVEL; HUMAN; IRON OVERLOAD; KOLMOGOROV SMIRNOV TEST; LEUKOCYTE COUNT; LIPID PEROXIDATION; MALE; OXIDATIVE STRESS; RISK ASSESSMENT; SICKLE CELL ANEMIA; THROMBOCYTE COUNT; TRANSFERRIN BLOOD LEVEL;

ADULT; ANEMIA, SICKLE CELL; BLOOD TRANSFUSION; FEMALE; FERRITINS; HUMANS; IRON OVERLOAD; MALE; MALONDIALDEHYDE; NITRITES; OXIDATIVE STRESS;

EID: 84870936378     PISSN: 17520363     EISSN: 17520371     Source Type: Journal    
DOI: 10.2217/bmm.12.71     Document Type: Article

References (26)

1. Naoum PC. [Erythrocyte and environmental Interfering in sickle cell disease]. Rev. Bras. Hematol. Hemoter. 22(1), 5-22 (2000
2. Sheng K, Shariff M, Hebbel RP. Comparative oxidation of hemoglobins A and S. Blood 91(9), 3467-3470 (1998
3. Fibach E, Rachmilewitz E. The role of oxidative stress in hemolytic anemia. Curr. Mol. Med. 8(7), 609-619 (2008
4. Goulart MOF, Vasconcelos SML, Moura JBF, Benfato MS, Manfredini V, Kubota LT. [Reactive oxygen and nitrogen species, antioxidants and markers of oxidative damage in human blood: Main analytical methods for their determination]. Quím. Nova 30(5), 1323-1338 (2007
5. David JM, Barreiros ALBS, David JP. [Oxidative stress: Relations between the formation of reactive species and the organism's defense]. Quim. Nova 29(1), 113-123 (2006
6. Ferreira AL, Matsubara LS. [Free radicals: Concepts, related diseases, and oxidative stress defense system]. Rev. Ass. Med. Brasil 43(1), 61-68 (1997
7. Shander A, Cappellini MD, Goodnough LT. Iron overload and toxicity: The hidden risk of multiple blood transfusions. Vox Sang. 97(3), 185-197 (2009
8. Ward R. An update on disordered iron metabolism and iron overload. Hematology 15(5), 311-317 (2010
9. Gladwin MT, Shelhamer JH, Ognibene FP et al. Nitric oxide donor properties of hydroxyurea in patients with sickle cell disease. Br. J. Haematol. 116(2), 436-444 (2002
10. Neto PFT, Gonçalves RP, Elias DBD, Araújo CP, Magalhães HIF. Analysis of oxidative status and biochemical parameters in adult patients with sickle cell anemia treated with hydroxyurea, Ceará. Rev. Bras. Hematol. Hemoter. 33(3), 207-310 (2011
11. Končić MZ, Barbarić M, Perković I, Zorc B. Antiradical, chelating and antioxidant activities of hydroxamic acids and hydroxyureas. Molecules 16(8), 6232-6242 (2011).
12. Draper HH, Hadley M. Malondialdehyde determination as index of lipid peroxidation. Methods Enzymol. 186, 421-431 (1990
13. Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR. Analysis of nitrate, nitrite and (15N) nitrate in biological fluids. Anal. Biochem. 126(1), 131-138 (1982
14. Taniguchi N, Gutteridge JMC. Glutathione peroxidase; coupled enzyme assay. In: Experimental Protocols for Reactive Oxygen and Nitrogen Species. Oxford University Press, Oxford, UK, 79-82 (2008
15. Hundekar P, Suryakar A, Karnik A, Ghone R, Vasaikar M. Antioxidant status and lipid peroxidation in sickle cell anaemia. Biomed. Res. 21(4), 461-464 (2010
16. Titus J, Chari S, Gupta M, Parekh N. Pro-oxidant and anti-oxidant status in patients of sickle cell anaemia. Ind. J. Clin. Biochem. 19(2), 168-172 (2004
17. Elias DBD, Freitas RM, Gonçalves RP, Magalhães HYF, Sousa JH, Magalhães SMM. [Evaluation of the concentration of malondialdehyde and nitrite in pacients with sickle cell anemia with hydroxyurea treated or not]. Einstein 8(4), 414-418 (2010
18. Cançado RD. [Iron overload and iron chelation in sickle cell disease.] Rev. Bras. Hematol. Hemoter. 29(3), 316-326 (2007
19. Walter BP, Fung EB, Killilea DW et al. Oxidative stress and inflammation in iron-overloaded patients with b-Thalassaemia or sickle cell disease. Br. J. Haematol. 135(2), 254-263 (2006
20. Gonçalves RP, Elias DB, Magalhães HI, de Souza JH. Study of correlation of nitrite levels with malondialdehyde and the prognosis of patients with sickle cell disease on hydroxyurea, Ceará-Brazil. J. Clin. Lab. Anal. 25(5), 369-373 (2011
21. Mack AK, Kato GJ. Sickle cell disease and nitric oxide: A paradigm shift? Int. J. Biochem. Cell. Biol. 38(8), 1237-1243 (2006
22. Lou TF, Singh M, Mackie A, Li W, Pace BS. Hydroxyurea generates nitric oxide in human erythroid cells: Mechanisms for g-globin gene activation. Exp. Biol. Med. (Maywood) 234(11), 1374-13782 (2009
23. Rusanova I, Escames G, Cossio G et al. Oxidative stress status, clinical outcome, and b-globin gene cluster haplotypes in pediatric patients with sickle cell disease. Eur. J. Haematol. 85(6), 529-537 (2010
24. Wood KE, Granger DN. Sickle cell disease: Role of reactive oxygen and nitrogen metabolites. Clin. Exp. Pharmacol. 34(9), 926-932 (2007
25. Klings ES, Akinsheye I. Sickle cell anemia and vascular dysfunction: The nitric oxide connection. J. Cell. Physiol. 224, 620-625 (2010
26. Alsultan AL, Seif MA, Aminn TT, Naboli M, Alsuliman AM. Relationship between oxidative stress, ferritin and insulin resistance in sickle cell disease. Eur. Rev. Med. Pharmacol. Sci. 14(6), 527-538 (2010